+91 80 25594757 / 9844009935

+91 9844094888


RIMED Ltd., was established in 1982. Since then the company has been involved in the manufacture of non-invasive invasive Vascular & Transcranial Doppler systems. RIMED introduced into the market the first PC- based Peripheral Vascular Doppler and was also the first to introduce the customizable “summary screen” concept which has since been adopted by other companies. Since its inception, the RIMED has successfully launched 7 generations of Transcranial Doppler systems. Currently, the company offers its state of the art, new line of digital Transcranial Dopplers:

(Digi-LiteTM and Digi-One TM) with M-Mode as well as an optional Carotid colour flow imaging module

With over 4000 installation worldwide, RIMED has become a reputable brand name in the field of Transcranial Doppler (TCD) technology. RIMED’s line of products carry all international certifications such as CE, ISO13485:2012, FDA. SFDA, K-FDA


Transcranial Doppler (TCD’s) technology based unit is a non-invasive, portable and safe technique that uses that uses high-frequency sound waves to measure the rate and direction of blood flow inside vessels . The test examines and records the speed of the blood flow in arteries known as the Circle of Willis, which are located at the base of the brain, to facilitate the diagnosis of a wide range of conditions affecting the brain such as:

  Subarachnoid haemorrhage (SAH) – Strokes

 Transient Ischemic Attack (TIA) - A brief stroke-like attack that, despite resolving within minutes to hours, still requires immediate medical attention to distinguish from an actual stroke.

  Sickle Cell Anaemia


  Cerebrovascular Accident (CVA)

  Cerebral Circulatory Arrest

While most different forms of ultrasonography make images of the tissue state studied, the TCD makes audible sounds that can be heard, recorded and examined which is an added advantage to the neurosonologist, stroke diagnosis focussed neurologists, neuro-anesthetists, Neuro-surgeons, ICU and Emergency wing specialist of hospitals. Additionally the TCD’s are also helpful in providing point of care diagnosis of a patient especially in cases of emergency and acute conditions which may add to the immobility of the patient.


  •  Non-invasive method enabling physicians to define moment-to-moment changes in cerebral blood flow velocities.
  •   Bedside assessment of cerebrovascular circulation hemodynamics.
  •   Continuous monitoring for emboli detection.
  •   Intra-operative and post-operative monitoring for identifying hypoperfusion, preoperative thrombosis, hyperperfusion syndrome and ongoing intra-arterial embolism.
  •   Absolutely safe. Contrast agents are not used, thereby avoiding allergic reactions and decreasing risk to the patient.

View Details